Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...

Confluent (NASDAQ:CFLT – Get Free Report) had its price target boosted by investment analysts at Guggenheim from $35.00 to $38.00 in a note issued to investors on Wednesday,Benzinga reports. The firm ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

Five-star-rated analyst Mark Mahaney at Evercore ISI has downgraded his rating from Buy to Hold on The Trade Desk (TTD) after ...

Riot Platforms is expanding into AI and high-performance computing partnerships while adding three new board members with ...

Evercore ISI analyst Mark Lipacis is shrugging off Wall Street's concerns about Nvidia Corp.'s stock as he recommends buying it ahead of the company's earnings report.

Wall Street investment bank Evercore ISI (EVR) is pounding the table on Nvidia (NVDA) stock ahead of the chipmaker’s upcoming ...

EVR's fourth-quarter results benefit from an increase in revenues from the Investment Management, and Investment Banking and Equities segments.

Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ETCompany ParticipantsKaty Haber - Managing Director, Investor ...

NEW YORK (AP) — NEW YORK (AP) — Evercore Inc. (EVR) on Wednesday reported net income of $140.4 million in its fourth quarter. The company, based in New York, said it had earnings of $3.30 per share.

Investing.com -- Evercore ISI lifted Juniper Networks (NYSE: JNPR) stock to Outperform from In-Line on Tuesday while maintaining a $40 price target. Juniper shares rose nearly 2% after the market open ...